Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Autoimmunity: Good or Bad for Neuroprotection?
1 April 2002. The old dogma that the brain and the immune system don't mix is crumbling. We now know that the CNS is not entirely privileged, and that immune cells do invade it under certain conditions. This realization, in part, led to the development of the failed Aβ42 vaccine, which has demonstrated effectively how poorly we still understand the interplay between the CNS and the immune system.

The immune system's role in repairing neurons is also something of a mystery. For example, though T cell infiltration after spinal cord injury is thought to contribute to the healing process, just how this occurs is controversial. Are T cells that recognize CNS antigens essential, or is it the recruitment of non-CNS-reactive cells that is important?

Philip Popovich and colleagues, at Ohio State University of Medicine and Public Health, have addressed this question in a paper in today's Journal of Neuroscience. The authors examined the recovery from spinal cord injury in transgenic mice engineered so that more than 95 percent of their T cells recognize myelin basic protein (MBP), versus wildtype.

The transgenic group showed consistently poorer recovery from spinal cord trauma. They exhibited much greater demyelination, more axon loss, and impaired lumbar reflexes compared to wildtype mice. They also had a much greater complement of pro-inflammatory cytokines in their spinal fluid, including IFN-γ, IL-1β, and TNFα.

"If neuroprotection is realized by inducing an auto-reactive response, it is probably as a result of other inflammatory cells that are recruited to the CNS along with the MBP-reactive cells," said Popovich. The authors also caution that people genetically predisposed to autoimmune diseases of the CNS may be adversely affected by autoreactive vaccine therapies. Interestingly in this regard, early indications are emerging that the encephalitis that grounded the Aβ42 vaccine trial may have resulted from a T-cell response, see IPSEN meeting report.-Tom Fagan.

Reference:
Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG. Pathological central nervous system autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapies. J. Neurosci. April 2002;(22):2690-2700. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad